Clinical Trials List
Protocol NumberLTS15823
2021-06-01 - 2021-06-15
Phase III
Terminated1
ICD-10Q61.2
Polycystic kidney, adult type
ICD-9753.13
Polycystic kidney, autosomal dominant
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Ya-Fei Yang Division of Nephrology
- 王怡寬 Division of Nephrology
- 郭慧亮 Division of Nephrology
- 周哲毅 Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
7 participants
-
Global
640 participants
